The dangerous drug attorneys at Wilson Law, P.A. are currently accepting cases on behalf of individuals in the Raleigh, Durham, and Chapel Hill area who have suffered a serious injury after taking the type 2 diabetes drugs Invokana and Invokamet. These drugs, which are part of a class of drugs called SGLT2 inhibitors, can potentially result in a variety of serious health issues, the most common of which is ketoacidosis (high levels of acid in the blood) and serious urinary tract infections, as warned by the FDA.
If you've suffered an Invokana or Invokamet injury, you may be entitled to recover compensation for your damages. You can learn about your rights and options by speaking to our Raleigh dangerous drug lawyers in person. Please call 919-890-0180 today to schedule your free consultation with Kimberly Wilson White.
Health Risks Associated with Invokana and Invokamet
Invokana and Invokamet are used to help patients with type 2 diabetes lower their blood sugar levels by helping the kidneys remove excess sugar through urine. Invokana was approved for use in 2013 and was the first sodium-glucose co-transporter 2 (SGLT2) inhibitor drug to enter the market. Invokamet was approved for use in 2014.
Since March 2013, the FDA has received over 20 reports of ketoacidosis among type 2 diabetes patients who have been taking SGLT2 inhibitors. In May 2015, the FDA issued a warning regarding the link between SGLT2 inhibitors and an increased risk of ketoacidosis. According to the FDA, you should seek medical attention immediately if you develop any of the following ketoacidosis symptoms:
- Breathing problems
- Abdominal pain
- Unusual sleepiness or fatigue
If not treated in a timely manner, ketoacidosis can potentially result in a diabetic coma and in serious cases, death.
In addition, Invokana and Invokamet have been linked to a variety of other dangerous health conditions, including:
- Heart attack
- Kidney failure
- Kidney stones
- Urinary tract infections
Currently, there hasn't been a recall issued for Invokana and Invokamet. However, the FDA is investigating whether these measures should be initiated.
The first wave of lawsuits against the manufacturers of Invokana and Invokamet has already been filed, and it's likely that many more cases will arise as additional Invokana/Invokamet injuries are reported. These lawsuits allege that:
- The drug manufacturers failed to adequately warn healthcare providers and patients of the serious risks associated with these drugs, including ketoacidosis, heart attack, stroke, and kidney failure
- The safety risks associated with these drugs were misrepresented by the drug manufacturers and marketers
- The side effects of these drugs weren't adequately studied prior to their receiving approval
- Had doctors and patients been properly warned, safer diabetes drugs would have been prescribed instead of Invokana or Invokamet
Kimberly Wilson White has more than 15 years of experience handling complex dangerous drug litigation. She has made this area of law a primary focus of her practice, and she has successfully held negligent pharmaceutical companies accountable for the injuries caused by their dangerous drugs in court.
In addition to her extensive litigation experience, Kimberly Wilson White has earned a Master's degree in Public Health, and she's given several presentations before the North Carolina General Assembly on the drug approval process. This unique background can be invaluable when battling the high-powered legal teams employed by the pharmaceutical companies.
Please contact Wilson Law, P.A. using the form or call 919-890-0180 today to schedule your free Invokana/Invokamet injury consultation. We serve clients throughout North Carolina, including Raleigh, Durham, and Chapel Hill.